Gritstone bio, Inc. (GRTS)
NASDAQ: GRTS · IEX Real-Time Price · USD
0.738
-0.001 (-0.15%)
Apr 24, 2024, 10:11 AM EDT - Market open

Gritstone bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Cash & Equivalents
65.2959.48104.57170.0657.4152.1839.0112.41
Short-Term Investments
16.29116.39108.35170.37100.9346.9525.1
Cash & Cash Equivalents
81.57175.86212.92171.06127.78153.1185.9537.51
Cash Growth
-53.62%-17.40%24.47%33.87%-16.55%78.13%129.17%-
Other Current Assets
5.867.017.674.333.54.532.530.88
Total Current Assets
87.44182.88220.59175.39131.27157.6488.4838.39
Property, Plant & Equipment
84.1238.8244.5443.4550.3429.4927.217.49
Long-Term Investments
5.299.3210.620.990000
Other Long-Term Assets
0.929.742.351.742.782.431.610.54
Total Long-Term Assets
90.3357.8857.5246.1853.1231.9228.828.03
Total Assets
177.77240.75278.11221.57184.39189.56117.346.42
Accounts Payable
3.828.694.239.584.624.833.940.76
Deferred Revenue
2.355.1320.3311.714.5218.8100
Current Debt
6.95.297.485.872.51000
Other Current Liabilities
14.2715.687.91-0.16-2.14-8.533.721.73
Total Current Liabilities
27.3434.839.9626.9919.515.117.652.49
Long-Term Debt
97.8735.0218.9419.2320.9910.4910.520
Other Long-Term Liabilities
0.710.153.138.629.5614.841.852.24
Total Long-Term Liabilities
98.5835.1722.0627.8430.5525.3312.372.24
Total Liabilities
125.9269.9762.0254.8350.0540.4420.024.73
Total Debt
104.7840.3226.4225.123.4910.4910.520
Debt Growth
159.88%52.60%5.26%6.85%123.93%-0.29%--
Retained Earnings
-659.56-521.07-401.38-326.3-220.99-126.4-61.63-20.25
Comprehensive Income
0-0.08-0.0700.02-0.09-0.07-0
Shareholders' Equity
51.85170.78216.09166.74134.34149.1297.2841.69
Net Cash / Debt
-23.2135.55186.5145.96104.29142.6275.4337.51
Net Cash / Debt Growth
--27.32%27.77%39.96%-26.88%89.07%101.11%-
Net Cash Per Share
-0.201.492.363.863.1115.9937.7322.43
Working Capital
60.1148.08180.63148.4111.77142.5380.8335.9
Book Value Per Share
0.451.882.744.414.0016.7248.6624.93
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).